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Prolonged Delivery of BMP-2 Using Heparin-Derivatized Collagen 
Scaffolds
M. Santos1, M. Philbrook2, M. DiMicco3, N. Moran3, A. Shiedlin2,
T. Butler2, R. Miller2, G. Matthews3;
1Drug And Biomaterial R&D, Genzyme, Cambridge, MA, United 
States of America, 2Drug And Biomaterial R&D, Genzyme, 
Cambridge, United States of America, 3Preclinical Biology, Genzyme, 
Framingham, United States of America
Purpose: We evaluated a method to covalently link heparin 
oligosaccharides to collagen and enhance the binding of bone 
morphogenic protein-2 (BMP-2) to this derivatized surface. Since 
BMP-2 activity is potentiated in the presence of heparin, we 
hypothesize that BMP-2 loaded heparin-derivatized scaffolds 
will prolong BMP-2 release and amplify BMP-2 activity, thereby 
improving its ability to repair cartilage. 
Methods and Materials: )FQBSJOPMJHPTBDDIBSJEFT	¥L%B
DPOUBJOJOH
aldehyde groups were prepared by treating heparin with nitrous 
acid. These oligosaccharides were coupled to two collagen scaffolds, 
Helistat® and MAIX™, in the presence of sodium cyanoborohydride to 
yield heparin contents of 18% and 6% w/w, respectively. 
Results: Table I shows that the in vitro release of BMP-2 was signifcantly 
slower for the heparin-derivatized scaffolds when compared to 
untreated matrices. Scaffold Untreated Heparinized Helistat 22% 4% 
MAIX 77% 16% Table I. Percent BMP-2 released from untreated versus 
heparin-derivatized collagen scaffolds over 14 days at 37oC. BMP-2 
eluted from a heparin-derivatized scaffold showed a 2-3 fold increase 
in alkaline phosphatase activity compared to growth factor eluted from 
controls. Implantation in a rat ectopic bone formation model showed 
that after 28 days, the degree of bone formation for heparin-derivatized 
BMP-2 scaffolds was similar to untreated scaffolds, with dense areas of 
bone localized at the implant margins. 
Conclusions: )FQBSJOEFSJWBUJ[FE DPMMBHFO TDBGGPMET TJHOJ¾DBOUMZ
slowed the release of BMP-2 while maintaining and potentially 
increasing growth factor activity. In vivo studies showed BMP-2 
activity was maintained on heparinized scaffolds. Retention of BMP-
BOEQPUFOUJBMBNQMJ¾DBUJPOPGJUTCJPBDUJWJUZDPVMECFCFOF¾DJBMJOB
cartilage repair situation. 
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/BOP¾CSFTDBGGPMETGSPNQ)&."BOE17"$IJUPTBOGPSDBSUJMBHF
tissue engineering
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Purpose: /BOP¾CFST IBWF B CJH QPUFOUJBM JO UJTTVF FOHJOFFSJOH
applications. Their topography is convenient for cell adhesion and 
proliferation. Poly(hydroxyethyl methacrylate), polyvinyl alcohol 
(PVA) and chitosan are biocompatible polymers widely used for 
medical practice. The aim of this work was to study chondrocyte 
QSPMJGFSBUJPOBOEEJGGFSFOUJBUJPOPOUIFTFOBOP¾CSPVTTDBGGPMET
Methods and Materials: Two kinds of scaffolds were prepared 
by electrospinning: scaffolds of copolymer of hydroxyethyl 
methacrylate and methacrylate sodium salt (pHEMA1/pHEMA2 
samples using different crosslinking method), composite scaffolds 
of polyvinylalcohol (PVA) and chitosan, such as PVA/Chitosan1 
and PVA/chitosan2 using different crosslinking method, and 
PVA/Chitosan3). Samples were seeded by rabbit chondrocytes 
and cultured for 7 days. Chondrocytes cultured on tissue culture 
plastic (TCP) were used as a control. Proliferation and viability of 
chondrocytes were tested using MTT test (on day 1, 3, and 7) and 
confocal microscopy; the presence of type II collagen was proved by 
JNNVOP¿VPSFTDFODF
Results: MTT test showed good cell adhesion on all scaffolds. On 
day 3, the highest proliferation was observed on pHEMA1 and TCP, 
the lowest on PVA/Chitosan3. After 7 days, the lowest absorbance 
was observed on PVA/Chitosan3, all other scaffolds including 
TCP showed the same high MTT absorbance. Good correlation 
between propidium iodide staining and MTT test was observed. 
*NNVOP¿VPSFTDFODF QSPWFE QSFTFODF PG UZQF ** DPMMBHFO PO BMM
scaffolds. 
Conclusions: Samples made from pHEMA and PVA/Chitosan 
with higher amount of chitosan (PVA/Chitosan1, PVA/Chitosan2) 
showed excellent chondrocyte proliferation. These scaffolds can be 
potentially used for cartilage repair. 
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3FEJGGFSFOUJBUJPOBOE)ZBMJOF4QFDJ¾D&YUSBDFMMVMBS.BUSJY1SPUFJO
Synthesis in Human Chondrocytes Cultured in a PCL Scaffold
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Purpose: 5IF SFEJGGFSFOUJBUJPO QSPMJGFSBUJPO BOE IZBMJOFTQFDJ¾D
extracellular matrix (ECM) protein synthesis of chondrocytes cultured 
in a polycaprolactone (PCL) scaffold were analysed. 
Methods and Materials: Gene expression of type II collagen and 
aggrecan was assessed (PCR) in cells from PCL, monolayer and pellet 
cultures. Ki-67 immunodetection was used to assess the proliferative 
activity of cells cultured. Chondrocytic differentiation was evaluated using 
S-100 immunodetection, and the synthesis, and deposition into scaffold 
pores, of type II collagen and glycosaminoglycan (GAG) were analysed 
by immunohistochemistry and Alcian blue staining, respectively. All 
parameters were assessed at 7, 14 and 28 days of cultures maintained in 
either FBS-containing medium (FCM) or ITS-containing medium (ICM). 
Results: Expression of type II collagen gene was lower in FCM than in ICM 
for all culture systems (p<0.05) at all times of measure. PCL scaffolds 
cultured in ICM were able to induce collagen gene expression more 
FG¾DJFOUMZUIBOQFMMFUBOENPOPMBZFSDVMUVSFT"HHSFDBOHFOFFYQSFTTJPO
EJEOPUWBSZTJHOJ¾DBOUMZBNPOH'$.DVMUVSFT *O *$. UIFNPOPMBZFS
DVMUVSFTIBETJHOJ¾DBOUMZIJHIFSMFWFMTPGBHHSFDBOHFOFFYQSFTTJPOUIBO
did either the PCL or pellet cultures. Chondrocytes in PCL scaffolds or 
pellets with FCM did not proliferate to a great extent but maintain their 
EJGGFSFOUJBUFE QIFOPUZQF GPS  EBZT -FWFMT PG IZBMJOFTQFDJ¾D &$.
protein synthesis, and protein deposition into the scaffold pores, were 
similar among PCL and pellet cultures grown in FCM and in ICM. 
Conclusions: Chondrocytes seeded in PCL scaffolds and cultured 
in medium supplemented with ITS and ascorbate, maintained their 
QIFOPUZQFBOEXFSFBCMFUPTZOUIFTJTFTQFDJ¾DQSPUFJOT
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Purpose: BMP-2 has been shown to direct marrow-derived 
mesenchymal stem cells toward chondrogenic differentiation. We 
hypothesize that delivery of recombinant BMP-2 to a microfractured 
cartilage lesion will improve tissue repair, and that different delivery 
vehicles could modulate the duration of exposure of joint tissues to 
BMP-2 stimulation. 
Methods and Materials: We used in vitro and in vivo models to study BMP-
2 elution kinetics and bioactivity after lyophilization onto three collagen 
scaffolds with distinct physical characteristics and formulations. 
Results: In a 14-day in vitro study, BMP-2 elution depended on the 
scaffold employed, with more dense scaffolds releasing BMP-2 more 
slowly, and to a lesser overall extent. Bioactivity was assessed by cell-
based assay, with an average of 81% of the released protein remaining 
active, and no differences among scaffolds. Bioactivity was also evaluated 
in vivo using BMP-2 loaded collagen scaffolds in a rat subcutaneous 
implant model. Although all scaffolds supported BMP-2-induced bone 
formation (indicating active BMP-2), the extent and spatial distribution 
PGCPOFEFQPTJUJPOWBSJFEBNPOHUIFTDBGGPMET$FMMJO¾MUSBUJPOJODSFBTFE
with scaffold porosity, with a higher total mineral deposition and a more 
homogeneous distribution over the 28-day implantation period in more 
porous scaffolds. 
Conclusions: Lyophilizing BMP-2 onto collagen scaffolds resulted in 
different release kinetics related to the scaffold physical properties, with 
overall maintenance of BMP-2 activity. Our preparation resulted in an 
easy-to-handle, unitary device suitable for implantation. Ongoing studies 
are investigating chemical modulation of scaffolds to alter the BMP-2 
elution rate, and testing these scaffolds in large animal models of 
cartilage repair. 
